Status:
COMPLETED
Involvement of Immune Cells Derived From the Intestine in Sjogren's Syndrome
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Sjogren's Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study aims at defining the role of immune cells derived from the intestine in the pathogenesis of Sjogren's disease. This research might open new therapeutic approaches for the treatment of autoim...
Detailed Description
Autoimmune diseases are characterized by a loss of tolerance of the immune system for self-antigens. One of the feature of autoimmune diseases is the infiltration of lymphoid cells in the tissues dama...
Eligibility Criteria
Inclusion
- Suspicion of Sjogren's syndrome based on 2016 American College of Rheumatology (ACR) criteria;
- Age ≥ 18 years
- Being affiliated to health insurance
- Willing to participate
Exclusion
- Pregnant or breastfeeding women,
- Patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent)
Key Trial Info
Start Date :
August 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 27 2022
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT03841318
Start Date
August 3 2020
End Date
September 27 2022
Last Update
February 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Bordeaux - Service de médecine interne
Bordeaux, France